“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11.
“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11.